A study to test the efficacy of a unique cannabis terpene formulation for the treatment of viral infections, including COVID-19, has shown early promising results.
France, Spain and Sweden detected their first cases of the new coronavirus strain that prompted fresh lockdown measures in Britain and global travel bans, authorities said.
